Chemist + Druggist is part of Pharma Intelligence UK Limited

This is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.


This copy is for your personal, non-commercial use. Please do not redistribute without permission.

Printed By

UsernamePublicRestriction

GPhC moves closer to covert surveillance

Practice The Home Office has backed the General Pharmaceutical Council’s bid for covert surveillance powers, the regulator has announced.

The General Pharmaceutical Council's (GPhC) is one step closer to securing covert surveillance powers, it has announced.


The GPhC was confident it had a "good case" for seeking greater powers to carry out mystery-shopper tests, chief executive Duncan Rudkin told C+D in an exclusive interview yesterday (April 15), after it received support from the Office of Surveillance Commissioners (OSC).


The GPhC agreed to pursue the extra powers, first reported by C+D in February, at its meeting last week (April 11) and has written to the Department of Health asking for a change in legislation.


"We'd be gathering evidence in those rare cases where we have reason to believe there may be something seriously untoward going on" Duncan Rudkin, GPhC

More on the GPhC

GPhC outlines shake-up after Mid Staffs report

GPhC pushes for covert surveillance powers

Pharmacists torn on GPhC's covert surveillance plans

Mr Rudkin said he was unaware of any other health-professional regulators seeking the same powers, but stressed that pharmacy regulation raised specific challenges.


"We're slightly different because we have this remit around enforcing and setting standards for pharmacy businesses," he told C+D. "So we'd be gathering evidence in those rare cases where we have reason to believe there may be something seriously untoward going on."


The GPhC announced its plans to pursue the extra powers after the BBC reported in December that nine London pharmacies were allegedly selling POMs, such as temazepam and Valium, illegally for cash.


Mr Rudkin said the GPhC's "good track record" in using its existing powers should strengthen its case. The regulator received a positive report from the OSC on its use of overt test purchases in January.


"We've got a clean bill of health from the surveillance commissioners... so we think we can say that we could be trusted to use these [extra] powers responsibly," he argued.


But Mr Rudkin could not commit to how long the plans would take to come to fruition and stressed it would be a "long process" to gain approval from the government.


"If the government agrees we should have [the powers], the next step would always be to find a way of updating the law and that often isn't straightforward," he revealed. "We're beginning that process so I think, at this stage, it wouldn't be too clever of me to put a timetable around it."


Is the GPhC right to seek covert surveillance powers?

Comment below or email us at [email protected] You can also find C+D on Twitter, LinkedIn and Facebook

Topics

         
Pharmacist Manager
Barnsley
£30 per hour

Apply Now
Latest News & Analysis
See All
UsernamePublicRestriction

Register

CD016151

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Thank you for submitting your question. We will respond to you within 2 business days. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel